Senior insider sale
Chief Commercial Officer at TARSUS PHARMACEUTICALS, INC. — senior position signals high conviction
$16.09M
220.07K shares
What this filing means
MOTTIWALA AZIZ plans to sell 220.07K shares of TARSUS PHARMACEUTICALS, INC. valued at approximately $16.09M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/2/2026ACC: 0001959173-26-006653
Officer· Chief Commercial Officer
Since Oct 2020
220.07K
Shares to sell
$16.09M
Approx. market value
8K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
7/27/2020
8KTotal acquired8K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/27/2020 | Stock Option Exercise Cash | 8K | — |
| Total | 8K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
77.70K
Market value
$5.75M
9/1/2026
—Completed
Units to sell
81.33K
Market value
$5.84M
8/25/2026
—Completed
Units to sell
53.04K
Market value
$3.84M
8/19/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
8K
Market value
$654.4K
9/2/2026
Total
Units
220.07K
Value
$16.09M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/1/2026 | 77.70K | $5.75M | — | Completed |
8/25/2026 | 81.33K | $5.84M | — | Completed |
8/19/2026 | 53.04K | $3.84M | — | Completed |
| Planned — Approximate Date | ||||
9/2/2026 | 8K | $654.4K | NASDAQ | Planned |
| Total | 220.07K | $16.09M | ||